Literature DB >> 13696666

Contact sensitivity in mice.

A J CROWLE, C M CROWLE.   

Abstract

Entities:  

Keywords:  ANTIHISTAMINICS/pharmacology; CORTISONE/pharmacology; DERMATITIS VENENATA/experimental; LYSERGIC ACID DIETHYLAMIDE/related compounds; NITROBENZENES/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13696666     DOI： 10.1016/0021-8707(61)90098-3

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  7 in total

1.  [IMMUNOLOGIC PRINCIPLES OF REMOTE ALLERGIC REACTION].

Authors:  G GILLISSEN
Journal:  Klin Wochenschr       Date:  1965-06-01

2.  Induction and modification of anti-TNP reaginic and IgG antibody responses by reactive trinitrophenyl derivatives.

Authors:  W R Thomas; M C Watkins; S S Jouhal; G L Asherson
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

Review 3.  Cells involved in cell-mediated and transplantation immunity. II. A consideration of the functional identity of the cells involved in both humoral and cell-mediated immunity: a phylogenetic approach.

Authors:  M Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

4.  Anti-DNP antibody response after the topical application of DNFB in mice.

Authors:  C Takahashi; S Nishikawa; Y Katsura; T Izumi
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

5.  Experimental studies on skin hazard with "Versatic" 9-II acid and its monoglycidyl and vinyl esters.

Authors:  C G Hunter; V K Brown; L W Ferrigan
Journal:  Br J Ind Med       Date:  1966-04

6.  Cyclophosphamide intensifies the acquisition of allergic contact dermatitis in mice rendered B-cell deficient by heterologous anti-IgM antisera.

Authors:  H C Maguire; L Faris; W Weidanz
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

Review 7.  From Mysterious Supernatant Entity to miRNA-150 in Antigen-Specific Exosomes: a History of Hapten-Specific T Suppressor Factor.

Authors:  Włodzimierz Ptak; Katarzyna Nazimek; Philip W Askenase; Krzysztof Bryniarski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-18       Impact factor: 4.291
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.